be visible on the BioBusiness market ISSN 2300-0228
Find us on:
Final Report - analytica closes with record-breaking visitor attendance
The 26th analytica m...
MINICUBE PCR A NEW TOOL FOR GENETIC RESEARCH
The importance of research in our genes cannot ...
Bioeconomy drives Lodzkie. Americans are looking up to us
Close to a thousand participants, ...
Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidate
Pharnext Announces Positive Topline Results from Pivotal Phase 3 Trial of PXT3003 for Treatment of Charcot-Marie-Tooth Type 1A Disease
Tag: Hexaell Biotechnologies
Show search box
Publish date from
Shanghai-Based Hexaell Biotech Secures 50 million RMB ($7.3 million) Series A Financing From Hyfinity Investments
The funding will be used to support the clinical and CFDA registration of the hiHep cell engineering system and further accelerate Hexaell's research and development in liver diseases and cell engineering pipeline ...
The most popular tags